Publications
Publications
Show Results For
- All HBS Web
(37,694)
- Faculty Publications (9,542)
- May 2023 (Revised June 2023)
- Case
Novartis (A): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
- May 2023 (Revised June 2023)
- Supplement
Novartis (B): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
- May 11, 2020
- Article
Steer Your Family Businesses Through an Unplanned Transition
By: Josh Baron and Nick Di Loreto
In a perfect world, family businesses will transition leadership from one generation to the next along a predictable and well-planned process — whether that’s determined within the business, the ownership group, or the family itself — passing the baton after years of... View Details
- May 9, 2023
- Article
8 Questions About Using AI Responsibly, Answered
By: Tsedal Neeley
Generative AI tools are poised to change the way every business operates. As your own organization begins strategizing which to use, and how, operational and ethical considerations are inevitable. This article delves into eight of them, including how your organization... View Details
- 2023
- Working Paper
El Dorado Lost: Local Elites, Real Estate and the Education Business in China
By: Geoffrey Jones and Yuhai Wu
This working paper examines the evolving, complex and multifaceted relationship between the real estate industry and the education sector in China. The current crises in the private education and real estate sectors caused by policy shifts reflect the inter-meshing of... View Details
- 2023
- Working Paper
Setting Gendered Expectations? Recruiter Outreach Bias in Online Tech Training Programs
By: Jacqueline N. Lane, Karim R. Lakhani and Roberto Fernandez
Competence development in digital technologies, analytics, and artificial intelligence is increasingly important to all types of organizations and their workforce. Universities and corporations are investing heavily in developing training programs, at all tenure... View Details
- May 2, 2023
- Editorial
Onboarding NextGens
By: Christina R. Wing and Rohit K. Gera
The process of onboarding the next generation into a family business can be both fulfilling and challenging. In many cases, the NextGen feel that they have been a part of the family business for their entire lives, and taking their place within the company feels... View Details
- May 2023
- Article
A Public Health Approach to Negative News Media: The 3-to-1 Solution
By: Tyler VanderWeele and Arthur C. Brooks
There is clear evidence that the prevalence of negative media reporting has increased substantially over the past years. There is evidence also that this negative reporting adversely affects social interactions, as well as health and well-being outcomes. Given the wide... View Details
- 2023
- Working Paper
Causes and Consequences of State Violence against Civilians: The Rohingya of Myanmar
By: C. Austin Davis, Paula Lopez-Pena, A. Mushfiq Mobarak and Jaya Wen
The Rohingya crisis is a severe, ongoing conflict involving large-scale violence and forced displacement, yet its causes are contested and its consequences lack systematic documentation. We marshal a variety of existing and original data to shed light on its drivers,... View Details
- March 2023
- Article
Developing Moral Muscle in a Literature-based Business Ethics Course
By: Inge M. Brokerhof, Sandra J. Sucher, P. Matthijs Bal, Frank Hakemulder, Paul G. W. Jansen and Omar N. Solinger
Moral subjectivity (e.g., reflexivity, perspective-taking) is a necessary condition for moral
development. However, widely used approaches to business ethics education, rooted in
conceptualizations of ethical development as objective and quantifiable, often neglect... View Details
- April 2023
- Supplement
Fresh Food Generation
By: Brian Trelstad
Instructors should consider the timing of making videos available to students, as they may reveal key case details.
This case highlights one of five BIPOC entrepreneuers in the Boston area as part of the HBS Impact Investment Fund. In fall 2021, a team of... View Details
This case highlights one of five BIPOC entrepreneuers in the Boston area as part of the HBS Impact Investment Fund. In fall 2021, a team of... View Details
- April 27, 2020
- Article
A Crisis Playbook for Family Businesses
By: Josh Baron and Ben Francois
In a business crisis, the power of family business owners is magnified. Unlike public companies, which typically focus on maximizing shareholder value, family owners value objectives that usually go well beyond financial returns (e.g., family legacy, reputation). This... View Details
- April 2023 (Revised January 2024)
- Background Note
Note on Healthcare in Ghana
By: Regina E. Herzlinger and Ben Creo
This note provides an overview of the healthcare system in Ghana. It discusses the public and private sector as well as traditional medical practice. It also discusses the country’s pharmaceutical industry. It is recommended as a companion to Professor Regina... View Details
Keywords: Africa; Pharmaceutical Companies; Pharmacy Benefit Manager; Health Care; Health Care Costs; Health Care Delivery; Health Care Entrepreneurship; Telehealth; Health Equity; Governing Rules, Regulations, and Reforms; Health Care and Treatment; Business and Government Relations; Health Industry; Pharmaceutical Industry; Ghana
- April 2023
- Case
Elliott Management: Capital Allocation in Biopharma
By: Amitabh Chandra, Paul Clancy and Lauren Gunasti
The case explores the intersection of capital allocation and shareholder activism in the biopharmaceutical industry. As many biopharma companies face looming patent expirations for key medicines, the case asks the question of whether investing in R&D and M&A is an... View Details
- April 2023 (Revised April 2024)
- Teaching Note
Netflix's Culture: Binge or Cringe?
By: Hubert Joly, Leonard A. Schlesinger, James Barnett and Stacy Straaberg
Teaching Note for HBS Case No. 522-096. View Details
Keywords: Compensation and Benefits; Employees; Recruitment; Resignation and Termination; Retention; Selection and Staffing; Innovation and Management; Innovation Strategy; Leadership Style; Business or Company Management; Management Style; Media; Business Processes; Organizational Culture; Organizational Structure; Performance Expectations; Performance Productivity; Creativity; Business Strategy; Entertainment and Recreation Industry; Entertainment and Recreation Industry; Entertainment and Recreation Industry; Entertainment and Recreation Industry; North America; California; Canada; Europe; Middle East; Africa; Asia; Latin America
- April 2023 (Revised September 2023)
- Case
Apple's iPhone Revolution: Pioneering the Circular Economy
By: George Serafeim
When asked to identify an example of a circular economy business model that has generated billions in revenues for a company, ChatGPT, the famous chatbot that in 2022 rocked the world with its ability to perform a variety of tasks, immediately identified and... View Details
- May 4, 2023
- Article
Falling Insulin Prices—What Just Happened?
By: Leemore S. Dafny
Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had long been building, so why would they act now? View Details